Health ❯Healthcare ❯Biotechnology

Drug Development

Gilead Sciences FDA Approval

FDA Approves Zanidatamab for Advanced HER2-Positive Biliary Tract Cancer

Lenacapavir Injection Shows 96% Efficacy in Preventing HIV